Karl Welzenbach

2.3k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Karl Welzenbach is a scholar working on Immunology and Allergy, Immunology and Molecular Biology. According to data from OpenAlex, Karl Welzenbach has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology and Allergy, 10 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Karl Welzenbach's work include Cell Adhesion Molecules Research (11 papers), Immune Response and Inflammation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karl Welzenbach is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Immune Response and Inflammation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karl Welzenbach collaborates with scholars based in Switzerland, United States and Austria. Karl Welzenbach's co-authors include Gabriele Weitz‐Schmidt, Ulrich Hommel, Joerg Kallen, Sylvain Cottens, Volker Brinkmann, Yoshikazu Takada, Christian Bruns, Paul Ramage, Dieter Geyl and Richard W. Kriwacki and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Molecular Biology.

In The Last Decade

Karl Welzenbach

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

2001 844 citations Gabriele Weitz‐Schmidt, Karl Welzenbach et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Welzenbach Switzerland	15	636	586	434	353	207	18	1.7k
Gabriele Weitz‐Schmidt Switzerland	23	753 1.2×	965 1.6×	598 1.4×	626 1.8×	318 1.5×	48	2.5k
Eugene Trogan United States	9	1.2k 1.9×	761 1.3×	511 1.2×	269 0.8×	279 1.3×	9	2.1k
Takaki Hiwasa Japan	25	397 0.6×	1.3k 2.2×	174 0.4×	131 0.4×	474 2.3×	132	2.1k
Bart J.M. van Vlijmen Netherlands	26	482 0.8×	661 1.1×	568 1.3×	110 0.3×	213 1.0×	70	2.1k
Jonathan E. Feig United States	25	1.2k 2.0×	925 1.6×	1.0k 2.4×	117 0.3×	303 1.5×	35	3.1k
Orr Sharpe United States	19	354 0.6×	497 0.8×	121 0.3×	122 0.3×	182 0.9×	25	1.5k
Simone R. Green United States	13	603 0.9×	458 0.8×	326 0.8×	123 0.3×	292 1.4×	13	1.2k
Andrej Skerjanec Switzerland	19	332 0.5×	705 1.2×	138 0.3×	112 0.3×	669 3.2×	44	1.9k
Lisa Happerfield United Kingdom	27	339 0.5×	995 1.7×	411 0.9×	79 0.2×	656 3.2×	43	2.4k
Eduardo Farias United States	29	425 0.7×	1.4k 2.4×	214 0.5×	183 0.5×	774 3.7×	67	2.7k

Countries citing papers authored by Karl Welzenbach

Since Specialization

Citations

This map shows the geographic impact of Karl Welzenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Welzenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Welzenbach more than expected).

Fields of papers citing papers by Karl Welzenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Welzenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Welzenbach. The network helps show where Karl Welzenbach may publish in the future.

Co-authorship network of co-authors of Karl Welzenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Welzenbach. A scholar is included among the top collaborators of Karl Welzenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Welzenbach. Karl Welzenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Feuerbach, Dominik, Patrick Schindler, Carmen Barske, et al.. (2017). ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neuroscience Letters. 660. 109–114. 109 indexed citations

Welzenbach, Karl, et al.. (2016). Downstream effect profiles discern different mechanisms of integrin αLβ2 inhibition. Biochemical Pharmacology. 119. 42–55. 6 indexed citations

Welzenbach, Karl, et al.. (2015). A novel multi‐parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood. British Journal of Pharmacology. 172(20). 4875–4887. 2 indexed citations

Van, Vu Quang, et al.. (2010). Targeting SIRP‐α protects from type 2‐driven allergic airway inflammation. European Journal of Immunology. 40(12). 3510–3518. 15 indexed citations

Evenou, Jean-Pierre, Jürgen Wagner, Gerhard Zenke, et al.. (2009). The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation. Journal of Pharmacology and Experimental Therapeutics. 330(3). 792–801. 116 indexed citations

Högenauer, Klemens, Andreas Billich, Charles Pally, et al.. (2008). Phosphorylation by Sphingosine Kinase 2 is Essential for in vivo Potency of FTY720 Analogues. ChemMedChem. 3(7). 1027–1029. 16 indexed citations

Haas, Anna, Gisbert Weckbecker, & Karl Welzenbach. (2008). Intracellular Phospho‐Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot. Cytometry Part A. 73A(9). 799–807. 21 indexed citations

Albert, Rainer, Klaus Hinterding, Volker Brinkmann, et al.. (2005). Novel Immunomodulator FTY720 Is Phosphorylated in Rats and Humans To Form a Single Stereoisomer. Identification, Chemical Proof, and Biological Characterization of the Biologically Active Species and Its Enantiomer. Journal of Medicinal Chemistry. 48(16). 5373–5377. 116 indexed citations

Wattanasin, Sompong, Joerg Kallen, Michael Sabio, et al.. (2004). 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1. Bioorganic & Medicinal Chemistry Letters. 15(4). 1217–1220. 34 indexed citations

10.

Weitz‐Schmidt, Gabriele, Karl Welzenbach, Janet Dawson, & Joerg Kallen. (2004). Improved Lymphocyte Function-associated Antigen-1 (LFA-1) Inhibition by Statin Derivatives. Journal of Biological Chemistry. 279(45). 46764–46771. 55 indexed citations

11.

Ullrich, Thomas, Karl Baumann, Karl Welzenbach, et al.. (2004). Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain. Bioorganic & Medicinal Chemistry Letters. 14(10). 2483–2487. 18 indexed citations

12.

Wattanasin, Sompong, Rainer Albert, Claus Ehrhardt, et al.. (2003). 1,4-Diazepane-2-ones as novel inhibitors of LFA-1. Bioorganic & Medicinal Chemistry Letters. 13(3). 499–502. 40 indexed citations

13.

Schramm, René, et al.. (2003). A statin‐based inhibitor of lymphocyte function antigen‐1 protects against ischemia/reperfusion‐induced leukocyte adhesion in the colon. British Journal of Pharmacology. 140(2). 395–401. 26 indexed citations

14.

Welzenbach, Karl, Ulrich Hommel, & Gabriele Weitz‐Schmidt. (2002). Small Molecule Inhibitors Induce Conformational Changes in the I Domain and the I-like Domain of Lymphocyte Function-associated Antigen-1. Journal of Biological Chemistry. 277(12). 10590–10598. 66 indexed citations

15.

Weitz‐Schmidt, Gabriele, Karl Welzenbach, Volker Brinkmann, et al.. (2001). Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine. 7(6). 687–692. 844 indexed citations breakdown →

16.

Kallen, Joerg, Karl Welzenbach, Paul Ramage, et al.. (1999). Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain 1 1Edited by F. E. Cohen. Journal of Molecular Biology. 292(1). 1–9. 214 indexed citations

17.

Peri, Francesco, Pascal Dumy, Yoshihiro Yokokawa, et al.. (1999). Assembly of binding loops on aromatic templates as VCAM-1 mimetics. Journal of Peptide Science. 5(7). 313–322. 6 indexed citations

18.

Al‐Rubeai, Mohamed, Karl Welzenbach, David Lloyd, & Katherine A. Kentistou. (1997). A rapid method for evaluation of cell number and viability by flow cytometry. Cytotechnology. 24(2). 161–168. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact